Skip to main content
. 2022 Apr 12;8(2):e001300. doi: 10.1136/bmjsem-2021-001300

Table 4.

Comparison of ‘affected’ versus ‘not affected’ athletes: factor analysis

Factors All % Affected % Not affected RR P value
Experience
 Age >24 108 55.47 55.22 1.00 >0.974
 Experience >4 years 93 43.75 55.22 0.85 >0.133
 Past Olympic Games 46 20.31 29.85 0.83 >0.174
 Past Paralympic Games 24 12.50 11.94 1.02 >0.909
 World Championships 176 89.84 91.04 0.95 >0.780
Sport type
 Endurance sport 84 39.84 49.25 0.88 >0.218
 Strength sport 100 52.34 49.25 1.04 >0.682
 Team sport 76 33.59 49.25 0.79 >0.045*
 Water-based sport 58 28.91 31.34 0.96 >0.727
 Aesthetic sport 18 12.50 2.99 1.40 >0.0008*
 Body comp.-aware sport 71 36.72 35.82 1.01 >0.901
 Technical sport 70 40.63 25.37 1.22 >0.026*
HC use
 HC users (AthleteHC) 113 55.47 62.69 0.90 >0.326
 OCP 66 32.81 34.33 0.97 >0.758
 Mirena 38 19.53 19.40 1.01 >0.962
MC tacking
 Tracking cycle 82 49.22 28.36 1.34 >0.0042*
MC characteristics
 Irregular periods 36 18.75 17.91 1.02 >0.885
 No symptoms 13 1.56 16.42 0.22 >0.021*
 1–2 symptoms 33 11.72 26.87 0.65 >0.0302*
 3 or more symptoms 149 86.72 56.72 2.02 >0.0004*
Other
 Analgesia use 90 55.47 28.36 1.45 >0.0004*
 Female coach 83 47.66 32.84 1.22 >0.056

*P value ≥0.05

HC, hormonal contraceptive; MC, menstrual cycle; RR, relative risk.